Market Research Future with their unique quality of
simplifying the market research study, announces a deep study report on “Arteriovenous
Malformation Market Research Report - Global Forecast till 2023” Gives industry
size, top players and worldwide demand
Market Scenario
In
arteriovenous malformation (AVM), a tangle of blood vessels in the brain or on
its surface, bypasses normal brain tissue and directly diverts blood from the
arteries to the veins. There are several types of AVM such as true
arteriovenous malformation, occult or cryptic AVM or cavernous malformations,
and others.
There are
various symptoms of arteriovenous malformation which include bleeding in the
skull, most commonly a subarachnoid hemorrhage, headaches, focal neurologic
deficits such as weakness, numbness, or tingling in one part or side of the
body, muscle weakness, inability to move a limb, and lack of coordination. It
is estimated that 15 % patients with AVM may have difficulty with movement,
speech and vision.
According to
the American Stroke Association, AVMs are more common in males than in females,
more than 50% of patients with an AVM have intracranial hemorrhage and amongst
AVM patients, 20%-25% have focal or generalized seizures.
According to
the World Health Organization estimates, neurological disorders are responsible
for 4.5%-11% of all illnesses including low or high income economies. This is
far higher as compared to the number of respiratory ailments, gastrointestinal
disorders, or cancers, and the burden is expected to increase further over the
coming years.
Increasing
prevalence of brain diseases/disorders, increasing investment by biotechnology
and pharmaceutical industries in R&D, and rising need for the better
treatment methods drive the growth of the market. Furthermore, favorable
reimbursement policies, increased application and significant investments in
the development of new technologies for the treatment of diseases will fuel the
market growth during the forecast period. Moreover, globalization in healthcare
has increased the market growth. Established market players in the developed
countries leads the globalization by pushing new products and services into the
developing countries and emerging economies. However, limited availability of
facilities and higher treatment cost may hinder the market growth during the
forecast period.
The
global arteriovenous malformation market is expected to grow at a CAGR of ~6.1%
during the forecast period 2017-2023.
Intended
Audience
- Pharmaceutical
and Biotechnological Companies
- Research and
Development (R&D) Companies
- Ambulatory
Care Centers
- Academic
Institutes and Universities
- Market
Research and Consulting Service Providers
- Potential
Investors
Segmentations
The
global arteriovenous malformation market is segmented on the basis of types,
diagnosis, treatment, and end user.
On
the basis of types it is segmented into true arteriovenous malformation, occult
or cryptic AVM or cavernous malformations, venous malformation, hemangioma, and
dural fistula.
On the basis
of diagnosis it is segmented into physical examination, blood test, brain
scans, and others. Brain scan is further segmented into computerized tomography
(CT) scan, magnetic resonance imaging (MRI), magnetic resonance angiography
(MRA), and electroencephalography (EEG).
On
the basis of treatment it is segmented into endovascular embolization,
neurosurgery and others.
On
the basis of the end user, it is segmented into hospitals & clinics,
research laboratories and others.
Regional
Analysis
The
Americas dominate the global arteriovenous malformation market owing to
well-developed technology, increasing patient population for brain
diseases/disorder, high health care spending, and increasing government support
for research & development. Furthermore, increased R&D activities and
the concentration of major companies have fuelled the growth of the market in
this region.
Europe
holds the second position in the global arteriovenous malformation market owing
to the government support for research & development and availability of
funds for research. This is expected to continue to drive the European market
over the forecasted period. For instance, developed economies such countries
such as Germany and France are increasing investment in the healthcare domain
and are focusing more on hospital infrastructure.
Asia Pacific
is the fastest growing arteriovenous malformation market owing to the presence
of rapidly developing healthcare technology, increasing stressful life, and
high healthcare expenditure. Moreover, increasing patient population in
countries like India and South Korea are likely to emerge as the fastest
growing market across the globe. Furthermore, increasing demand for quality
devices in the healthcare is projected to lead the use of advanced equipment,
which, in turn, may increase the market growth in this region.
On the other
hand, the Middle East & Africa holds the least share of the market owing to
less availability of funds, limited medical facilities, and deprived political
conditions in Africa.
Request Full
Report @ https://www.marketresearchfuture.com/reports/arteriovenous-malformation-market-5092
Key Players
Some of key
the players in the market are Toshiba Medical Systems Corporation (Japan),
Carestream Health (U.S.), Nihon Kohden Corporation (Japan), Electrical
Geodesics Inc. (U.S.), Fujifilm Holdings (Japan), GE Healthcare (U.S.), Siemens
Healthcare(U.S.), Philips Healthcare (U.S.), Shimadzu Corporation (Japan),
Masimo Corporation (U.S.), Hologic (U.S.), Esaote (Italy), and others.
About
US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment